Reginald Frye Pharm.D., Ph.D., FCCP
Reginald Frye, Pharm.D., Ph.D., is the UF College of Pharmacy’s associate dean for faculty development and a professor and chair for the department of pharmacotherapy and translational research. He received a B.S. in Biology from Oglethorpe University, a Pharm.D. from Mercer University School of Pharmacy, and a Ph.D. in Clinical Pharmaceutical Sciences from the University of Pittsburgh School of Pharmacy. After completing graduate work, Dr. Frye remained on faculty at the University of Pittsburgh from 1995 until 2003, being promoted to Associate Professor with tenure in 2002. He joined the faculty at the University of Florida in July 2003 and in July 2012, he was promoted to Professor.
Division of Community-Based Pharmacotherapy
Michelle Z Farland Pharm.D., CDCES
Dr. Farland received her Doctor of Pharmacy degree from the University of Pittsburgh School of Pharmacy in 2005. She completed a pharmacy practice residency at Shands Jacksonville Medical Center (now UF Health at Jacksonville) in Jacksonville, Florida and a specialty residency in Ambulatory care/Primary care at the Virginia Commonwealth University Medical College of Virginia Hospitals in Richmond, Virginia. Dr. Farland joined the faculty of the University of Tennessee Health Science Center College of Pharmacy in 2007 and was promoted to Associate Professor in 2012 and professor in 2021. She then joined the faculty of the University of Florida in 2015.
She currently serves as the Division Head of Community-Based Pharmacotherapy, which encompasses faculty practicing in a variety of outpatient practice models. Her educational research focuses on outcomes of team-based learning and personal and professional development. Dr. Farland has been recognized by the American College of Clinical Pharmacy with the 2012 New Educator Award, by the Team Based Learning Collaborative (TBLC) in 2016 as a team-based learning consultant-trainer, and by the American Association of Colleges of Pharmacy (AACP) in 2017 as an Emerging Teaching Scholar. She also received an honorable mention for the AACP Innovations in Teaching Award in 2019.
Dr. Farland is the immediate past president of the Team-Based Learning Collaborative (TBLC), and is a member of the American Association of Colleges of Pharmacy (AACP), American College of Clinical Pharmacy (ACCP), and Phi Lambda Sigma Pharmacy Leadership Society (PLS). Dr. Farland has served as a national speaker in the areas of diabetes, team-based learning, collaborative learning teams, and situational judgement tests.
Dr. Butler is the Associate Vice President for Inclusion, Diversity and Health Equity for the University of Florida’s Health Science Center and Chief Diversity Officer for UF Health. She also serves as a Clinical Professor within the Department of Pharmacotherapy and Translational Research. Prior to joining UF, Dr. Butler was the Director of Diversity, Equity and Inclusion and a Clinical Professor of Pharmacy Practice at Southern Illinois University Edwardsville.
Her leadership and impact span broadly at the institutional level, nationally and in the community. She has been nationally recognized for her work receiving the Distinguished Alumni award, the highest alumni honor from her alma mater, the APhA Distinguished Achievement Award, Pharmacy Time’s Face of Pharmacy Award and the National Pharmaceutical Association Pharmacy Leadership Award. Her professional interests include health equity, inclusive practices and policies, cultural humility, bias, health literacy, underserved communities, and leadership development.
Dr. Butler received her Doctor of Pharmacy degree from Mercer University in Atlanta, GA. She completed a pharmacy practice residency at the University of Illinois at Chicago and has received extensive training in the area of diversity, equity and inclusion.
Teresa Cavanaugh Pharm.D., M.S., BCPS, FASHP
Teresa Cavanaugh received her Doctor of Pharmacy Degree from the University of Cincinnati College of Pharmacy in 2006. Upon graduation, she completed a pharmacy practice residency at The University Hospital in Cincinnati, which solidified her interest in practice-based research with transplant patients. She then completed a two-year fellowship in health outcomes research with a focus on liver transplantation. During her fellowship, she received board certification as a pharmacotherapy specialist, and a Master of Science degree in pharmacy administration with an emphasis on health outcomes research. Dr. Cavanaugh joined the faculty of the University of Cincinnati College of Pharmacy in 2009. Her practice site was an ambulatory liver transplant clinic. Dr. Cavanaugh was actively involved in both the American Society of Health-System Pharmacists where she served as Vice Chair and Chair of the Commission on Affiliate Relations and with the Ohio Society of Health-System Services where she served two terms as division director for Organizational Affairs and was elected president in 2014. In 2016, Dr. Cavanaugh became introductory pharmacy practice experiences coordinator and the co-curricular activities coordinator. She was promoted to clinical associate professor of pharmacy practice in August 2017. Her current research interests involve student mental health and identifying characteristics that lead to success in pharmacy school.
Emily J Cicali Pharm.D.
Emily Cicali, Pharm.D., received her Doctor of Pharmacy degree from Philadelphia College of Pharmacy, University of the Sciences in 2015. She then completed a Pharmacy Practice Residency at Tabula Rasa HealthCare in Geriatric Personalized Medicine. After her residency, she was hired to work Tabula Rasa HealthCare at as a Research Pharmacist, as well as adjunct faculty at the Philadelphia College of Pharmacy, focusing on clinical pharmacokinetics and pharmacogenomics implementation. In 2017 she decided to fully transition to academia, which led to her completion of a fellowship in pharmacogenomics at the University of Florida. Cicali is now a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research. Her clinical practice is within the UF Health Personalized Medicine Program and her research interests include clinical implementation of pharmacogenomics as well as further understanding the role of phenoconversion for optimal medication safety.
Kelsey Cook Pharm.D., BCPS
Kelsey Cook, Pharm.D., received her B.S. from the University of Maryland and her Pharm.D. from the University of North Carolina. She completed a PGY1 Pharmacy Practice Residency at Dell Seton Medical Center in Austin, Texas and a PGY2 Clinical Pharmacogenomics Residency at the University of Florida in Gainesville, Florida. Dr. Cook joined the University of Florida College of Pharmacy, Jacksonville campus as a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research in 2019. In her role, she supports the implementation of pharmacogenomics at Nemours Children’s Health. Dr. Cook is a board-certified pharmacotherapy specialist. Her research interests include clinical implementation of pharmacogenomics and pharmacogenomics in pediatrics.
Stacey D Curtis Pharm.D.
Stacey Curtis says her mantra lies within the Ralph Waldo Emerson quote, “The purpose of life is not to be happy. It is to be useful, to be honorable, to be compassionate, to have it make some difference that you have lived and lived well…” She completes the quote with her own ending, “then happiness will follow!” Curtis displays her love of life and energy in the various roles she plays within the college. Currently, she serves as the Course Coordinator for Professional Practice Skills Lab, Community Introductory Pharmacy Practice Experience, and Advanced Topics in Community Pharmacy. The latter, an elective she created herself, combines two of her life passions: student development through teaching and community pharmacy practice. Additionally she serves as Course Co-Coordinator for Principles of Systems-Based Practice and Pharmacy Management.
Outside of the classroom, she was appointed by Dean Julie Johnson to serve on the Recruitment, Admissions, and Retention Task Force and is a member of the Admissions Committee. She serves as a Brand Ambassador as well as the 2017-2018 Faculty Delegate for the American Association of Colleges of Pharmacy (AACP). To ensure her connections with students outside of the classroom, Curtis is the Faculty Advisor for National Community Pharmacists Association (NCPA), Gator Pharmacy Wellness (GPW), and Christian Pharmacists Fellowship International (CPFI). Faith, family, and friends provide a solid foundation and balance for Curtis on a day-to-day basis. She is a traveling nomad at heart. She loves spending quality time with her husband and 3 children, outdoor activities and mentoring professional pharmacy students.
Prior to her current endeavors, Curtis worked in the Office of Experiential Programs serving as a Regional Coordinator for the Gainesville, Panhandle, and out-of-state regions (5 years), the Lead Regional Coordinator (4 years), and as the Assistant Director (1 year). The college deems Curtis a “Community Pharmacy Expert” given her 20+ years of experience where she has had many roles including Staff Pharmacist, Pharmacy Manager, Pharmacist Trainer, Pharmacy Recruiter, Pharmacy Intern Coordinator, and of course Preceptor for many pharmacy students.
Eric A Dietrich Pharm.D., BCACP, CPC-A, CEMC, CPB
Dr. Dietrich is a Clinical Associate Professor within the Department of Pharmacotherapy and Translational Research. His work involves managing an Anticoagulation Clinic at UF Health Internal Medicine at Tower Hill monitoring warfarin as well as DOACs in addition to a multidisciplinary transitions of care clinic for patients with a recent acute myocardial infarction. Dr. Dietrich’s research interests include interventions aimed at reducing anticoagulation, hypertension, cardiovascular disease, and pharmacy billing and reimbursement for clinical services in collaborative clinical environments. Dr. Dietrich is a Board Certified Ambulatory Care Pharmacist as well as a Certified Professional Coder. Dr. Dietrich’s teaching focuses on anticoagulation and cardiovascular disease and he is the Program Director for the UF College of Pharmacy PGY2 Specialty Residency in Ambulatory Care. Dr. Dietrich’s wife, Nicole, is a pharmacist at the VA.
Eric F Egelund Ph.D., Pharm.D.
After completing his Pharm.D. at the University of Florida College of Pharmacy, Dr. Egelund enrolled in the Ph.D. program at the University of Florida. Dr. Egelund completed his graduate studies in the Department of Pharmacotherapy and Translational Research under the mentorship of Dr. Charles Peloquin, director of the Infectious Disease Pharmacokinetics Laboratory (IDPL) in Gainesville. Currently Dr. Egelund is a Clinical Associate Professor at the College of Pharmacy’s Jacksonville campus. In addition to this role Dr. Egelund works part-time at Walgreens and volunteers at HIV clinics when time permits.
John Gums Pharm.D., FCCP
Dr. Gums is the interim dean of the University of Florida College of Pharmacy. He also serves as a Professor of Pharmacy and Medicine in the Departments of Pharmacotherapy and Translational Research and Community Health and Family Medicine at UF and holds the title of Associate Dean for Clinical and Administrative Affairs in the UF College of Pharmacy. Gums received his undergraduate degree in pharmacy from the University of Wisconsin and his Doctor of Pharmacy degree from the Medical University of South Carolina. Subsequently, he completed a fellowship in Family Medicine at the Medical University of South Carolina. Dr. Gums joined the faculty at the University of Florida in 1985, and is actively involved in teaching in the colleges of Pharmacy and Medicine. He has received the Faculty Recognition Award from the College of Pharmacy and twice was selected as Teacher of the Year by the University of Florida, Department of Family Medicine.
Jessica C Huston Pharm.D.
Dr. Jessica Huston is a Clinical Assistant Professor with the University of Florida College of Pharmacy at the Jacksonville Campus. She received her Bachelor’s degree in Biology from the University of Florida and her Doctor of Pharmacy at Virginia Commonwealth University before completing a Post-Doctoral Fellowship in Clinical Research and Pharmaceutical Industry at the East Coast Institute for Research. Dr. Huston joined the University of Florida College of Pharmacy as an Adjunct Clinical Lecturer in 2019 and lectured for the Physician Assistant Program at Nova Southeastern University. Dr. Huston’s research interests include diabetes and heart failure, where she has served as a Sub-Investigator on many clinical studies.
Tracy E Leonard R.Ph., BCPP, BCACP, CDCES, CPh
Tracy Leonard, received her B.S. from the University of Florida in 1991. She earned her Board Certification as an Ambulatory Care Pharmacist (BCACP) in 2011 and her Board Certification as a Psychiatric Pharmacist (BCPP) in 2018. She was an IPPE & APPE preceptor while Pharmacy Manager at Winn Dixie Pharmacy and is currently an APPE preceptor at the College of Pharmacy Center for Quality Medication Management (CQM). She has been a Career Coach since 2014. She has experience in community and closed door pharmacies, as well as consultant pharmacy.
She is a lifelong learner and enjoys spending time with her family, friends and pets.
Robin M Li Pharm.D., BCACP, NBC-HWC
Robin Moorman Li is currently a Clinical Associate Professor with the University of Florida College of Pharmacy and serves as the Assistant Director of the Jacksonville campus. She received her Bachelor’s degree from Kansas State University in 1996 and completed her Doctor of Pharmacy at University of Kansas in 2000. Moorman Li completed a primary care residency at University of Mississippi Medical Center in 2001, and became a pharmacy practitioner with Shands Jacksonville from 2001 to 2008 where she created a pharmacist driven pain management clinic in a primary care clinic. In 2003, she began teaching part time with the University of Florida College of Pharmacy and transitioned to full time faculty with the College in 2008. Moorman Li practiced at the River Garden Hebrew Home for the Aged from 2008-2016 and is now practicing at UF Health Jacksonville in the Ambulatory Pharmacist ran Pain Management Clinic and also in the Center for Pain Management at UF Health Jacksonville.to Moorman Li completed the Take Courage Coaching program which focused on developing coaching skills to help patients suffering with chronic pain. She then became a National Board Certified Health and Wellness Coach to further develop her skills.
Stacy L Miller Pharm.D., M.B.A., BCACP
Stacy Miller received her Doctor of Pharmacy from Butler University in 2007. Upon graduation, she completed a PGY-1 with focus in ambulatory care at Florida Hospital, Celebration Health. Dr. Miller began her academic career as an Assistant Professor at the Sullivan University College of Pharmacy in 2008. During her time at Sullivan, during her time there she earned her Masters of Business Administration, was the Residency Program Director (RPD) for a program she started at Baptist Health Floyd and was also the RPD for a residency program at the Center for Health and Wellness. At Sullivan, she served as the Director of Student Affairs, a role in which she was responsible for creating and implementing the co-curriculum. The focus of Dr. Miller’s clinical practice is on anticoagulation management in the ambulatory care setting. Dr. Miller is a member of the American Pharmacy Association (APhA), American Association of Colleges of Pharmacy (AACP), and the American Society of Health-Systems Pharmacists (ASHP). For ASHP, Dr. Miller is a Residency Program Accreditation Surveyor. Dr. Miller joined the faculty at the University of Florida in 2019 as the Assistant Dean for Clinical Education. In that role, she plays a prominent role in overseeing the quality of experiential programs, developing innovative approaches in experiential education, and leading pre-and post-residency placement activities in the college.
Lisa S Miller Pharm.D., M.A.
Dr. Lisa Miller is the Assistant Dean of the Orlando Campus where she devotes her time to teaching, research, advising, and administration. Dr. Miller received a B.S. in Pharmacy from The Ohio State University, a Pharm.D. from University of Kentucky, and M.A. in Clinical Mental Health Counseling from Liberty University. She completed a postdoctoral clinical pharmacy residency at Wake Forest University Baptist Medical Center in Winston-Salem, NC and is a Board Certified Pharmacotherapy Specialist (BCPS). Prior to joining the UF College of Pharmacy, Dr. Miller held various roles at Wingate University School of Pharmacy including Professor, Director of Advanced Pharmacy Practice Experience, Assistant Dean for Faculty, and Vice Provost for Faculty Affairs. Her current research interests include women’s health, women’s mental health, and scholarship of teaching and learning.
Carol A Motycka Pharm.D., BCACP
Carol Motycka, graduated from the University of Florida with her Pharm.D. and completed a residency in Ambulatory Care at Florida Hospital in Orlando. After practicing at Florida Hospital for several years, Motycka joined the University of Florida to help build the College of Pharmacy program in Jacksonville. She is board certified in Ambulatory Care has completed fellowships in both leadership and education. Motycka has been published in multiple academic and clinical journals and has provided over 100 presentations in the field. She has received awards on the state and national level for her teaching, research, and leadership. Motycka is a strong advocate of the profession of pharmacy and serves the profession through public relations events in her community and professional organizations where she has served in multiple capacities including Speaker of the House for the Florida Pharmacy Association and President of Duval County Pharmacy Association. As assistant dean of the University of Florida College of Pharmacy Jacksonville Campus, Motycka spends her time teaching, completing research, advising and administrating.
Bradley N Phillips Pharm.D., BCACP
Bradley Phillips, Pharm.D., BCACP, is a Clinical Assistant Professor within the University of Florida Department of Pharmacotherapy and Translational Research at the College of Pharmacy. Dr. Phillips graduated from the University of Florida College of Pharmacy in 2018. He then went on to complete his PGY1 residency and teaching certificate at AdventHealth Celebration the following year. Post-residency, he had the opportunity to continue his career at AdventHealth Celebration where he worked as a clinical pharmacy specialist and precepted both residents and rotational students. He is board certified in ambulatory care and his interest areas include academia, medication management, anticoagulation, and transitions of care. Dr. Phillips hopes to continue making a meaningful impact in his patients’ lives while educating the next generation of pharmacists. Outside of the hospital, he enjoys spending time with family and attending sporting events.
Jason Powell Pharm.D., BCACP
Dr. Powell’s clinical practice is based at the UFHealth Family Medicine Clinic at Eastside and Main St, where he oversees a pharmacy resident and a pharmacy fellow along with APPE students during their clinical training. Dr. Powell received his Pharm.D. degree from the University of Florida and completed a PGY-1 residency in Ambulatory Care at Eastside under the direction of Drs. Karen Sando and Jim Taylor. During residency training, he also completed the teaching certificate program at the UF College of Pharmacy and was actively involved in the training of IPPE, APPE, and WPPD students.
Joshua Pullo Pharm.D., C.Ph.
Joshua Pullo comes to UF from CVS Health, where he practices as a community pharmacy manager. Joshua received his Doctor of Pharmacy degree from the University Of Florida College Of Pharmacy in 2010. Since graduating, Dr. Pullo has been involved in various leadership roles in the academic and community setting. He has also serves as a preceptor for students on community IPPE and APPE rotations. His primary interests include student leadership development, geriatrics, global outreach, and community pharmacy. He is an advocate for LGBT+ issues on and off campus. His areas of research include student engagement and motivation.
Joshua is a licensed Consultant Pharmacist and also serves as an Expert Witness in pharmacy litigation. Joshua was recognized as 2019 recipient of the Exemplary Teaching Award. He has also been a part of the 2018 Outstanding Teaching Team award. In his time at CVS, Joshua was also named the Division 4 Paragon Award recipient, a recognition of his outstanding patient service in pharmacy.
Teresa E Roane PharmD, MBA, BCACP
Dr. Roane joined the faculty of the College of Pharmacy at the University of Florida (UF) in March 2010 as a Clinical Assistant Professor. Currently, she is also the Director of UF’s online medication therapy management (MTM) graduate program, Assistant Director of the online Individualized Medicine graduate program, and the Director of the PharmD MTM professional certificate program. She spends the majority of her time teaching within the PharmD curriculum as well as the online programs. Her clinical practice activities as of December 2021 includes working with the College of Pharmacy’s Continuing Pharmacy Education Department where she helps create content and facilitates training sessions for various clinical programs such as the collaborative practice agreement certification, immunization trainings, and pharmacy-based test and treat certificate program. For the eleven years prior, her clinical practice site was located at the College of Pharmacy’s Center for Quality Medication Management (CQM)–a clinical call center supported by contracts and grants offering MTM services to patients on behalf of national healthplans. While with CQM, Dr. Roane served in various roles including the Center Director, Director of Clinical Development, Clinical Operations Director, and Residency Program Director. Her teaching activities focuses on topics such as MTM, managed care, effective communications, business concepts, and vaccinations/immunizations. Before joining UF, Dr. Roane was as a Clinical Pharmacist at AvMed Health Plans, a managed care organization, where she helped develop and lead the organization’s first MTM program, provided direction to and oversight of the utilization management program, and served as the APPE preceptor for UF PharmD students. Dr. Roane received her Doctor of Pharmacy degree from the UF College of Pharmacy and her Master of Business Administration in HealthCare Management (MBA) degree from Western Governor’s University. She also obtained board certification as an ambulatory care pharmacist and holds her consultant pharmacist license. She serves on various committees for the College of Pharmacy as well as several state and national pharmacy organizations including the Florida Affiliate of AMCP, Alachua County Association of Pharmacists (ACAP), the Academy of Managed Care Pharmacy (AMCP), and the Pharmacy Quality Alliance (PQA).
Casey A Rowe Pharm.D.
Dr. Casey Rowe received her Doctor of Pharmacy degree from the University of Pittsburgh School of Pharmacy in 2019 and completed a PGY-1 pharmacy practice residency program at the Center for Quality Medication Management (CQM) at the University of Florida (UF) in 2021. After completing her residency program, she began working as a clinical pharmacist at CQM providing MTM services to patients and was instrumental in the successful launch of CQM’s electronic prior authorization program. In December 2021, Dr. Rowe transitioned to a faculty position as an Instructional Assistant Professor for the UF College of Pharmacy where she will continue to focus on medication management and patient care.
Janet Schmittgen Pharm.D.
Dr. Janet Schmittgen received her Doctor of Pharmacy Degree from the University of Florida, College of Pharmacy Working Professional Pharm.D. Program in 2019. She received her B.S. in Pharmacy from The Ohio State University in 1986. She practiced at several hospital pharmacies including; Kettering Memorial Hospital in Kettering, OH, Mount Carmel Medical Center in Columbus, OH, and Santa Teresita Hospital in Duarte, CA. She has also practiced in both Independent and Chain Community Pharmacy settings. She accepted a position as Instructor of Pharmacy Practice at Washington State University in Pullman, Washington in 1996 and served as Coordinator of the Pharmaceutical Care Laboratory and Instructor of Record for three courses in the entry level Pharm D curriculum. She also practiced at Express Scripts as a Clinical Pharmacist specializing in Prior Authorizations.
Currently she is a Instructional Assistant Professor at University of Florida College of Pharmacy in Gainesville and serves as the Teaching Partnership Leader for the 2PD Skills Laboratory course (PHA5163/5164). She also assists with Continuing Professional Education in the College of Pharmacy. She has a special interest in Pharmacy History. She serves as Director for the Pharmacy Museum at UF COP and teaches a 2-credit hour elective course in History of Pharmacy.
Janel Soucie Pharm.D.
Dr. Soucie received her Doctor of Pharmacy degree from Nova Southeastern University College of Pharmacy, following which she completed a Primary Care Pharmacy Residency at Florida Hospital Celebration Health. Since that time, she has practiced in a variety of settings, including as a staff pharmacist in both the inpatient and community pharmacy settings, and, primarily, in the area of ambulatory care which is her current area of clinical practice. She served as Adjunct Clinical Faculty for the University of Florida College of Pharmacy for many years before joining the college in 2016 in her current position. In addition to her role as an Orlando Regional Coordinator for the University of Florida College of Pharmacy Office of Experiential Programs (OEP), she serves as the OEP Disability Resource Center (DRC) Liaison for experiential accommodations.
Erin L St. Onge Pharm.D.
Erin St. Onge, Pharm.D., joined the faculty in July 2002 to help start the University of Florida College of Pharmacy program in Orlando.
St. Onge graduated from the University of Florida College of Pharmacy with her Doctor of Pharmacy degree with honors in 1999. Upon graduation, she completed a residency in Community Clinical Pharmacy with St. Louis College of Pharmacy/Walgreens. Dr. St. Onge accepted her first faculty position with Texas Tech University School of Pharmacy at their Lubbock campus. During her two years with Texas Tech, she gained valuable experience with their 3-campus (Amarillo, Lubbock, Dallas) distance education program. Also, she developed a community site for 3rd and 4th year students, as well as a residency program in Community Clinical Pharmacy. Dr. St. Onge and her family moved to Orlando in summer of 2002 at which time she accepted the position as Campus Director for Orlando. Dr. St. Onge has practiced ambulatory care in a variety of settings. She currently holds a joint appointment with the University of Central Florida College of Medicine where she provides clinical pharmacy services to patients at UCF Health. Additionally, Dr. St. Onge is very involved with interprofessional education initiatives with several schools/colleges within the University of Central Florida (Medicine, Nursing, Social Work, Physical Therapy, etc). The group was recently awarded the inaugural IPEC/USPHS National Award for Excellence in Interprofessional Education for their efforts at a student/faculty run clinic in Apopka, Florida. In addition to her current position with UF College of Pharmacy, she is very active in national pharmacy organizations and has held numerous leadership positions in state and local pharmacy organizations. Dr. St. Onge’s interests include diabetes mellitus, cardiovascular disease, and women’s health.
Kimberly Stultz Pharm.D.
Dr. Stultz joined the University of Florida College of Pharmacy in Gainesville in October 2018. She received her Doctor of Pharmacy degree in 2009 from the University of Florida College of Pharmacy. Upon graduation, she was awarded the Lydia Foote Leadership & Service Award for her contributions to student organizations including APhA-ASP and Student Council. From 2009-2016, Dr. Stultz served as an Assistant Pharmacy Manager for Publix Supermarkets. From 2011-2016, Dr. Stultz was an IPPE & APPE preceptor for three colleges of pharmacy: University of Florida, LECOM, and University of New England in Maine. She was recognized as Preceptor of the Year in 2014 by LECOM School of Pharmacy. From 2014-2016, she was a Career Coach and Course Facilitator for the University of Florida on the St. Petersburg Campus. Most recently, Dr. Stultz served as the Director of Experiential Education for Lake Erie College of Osteopathic Medicine, School of Pharmacy, in Bradenton, FL from 2016-2018.
James Taylor Pharm.D., CDE, BCACP
Dr. Taylor is a clinical professor in the Department of Pharmacotherapy and Translational Research at The University of Florida College of Pharmacy. He received his doctor of pharmacy degree from Ohio Northern University. Upon graduation, he completed an ASHP accredited Pharmacy Practice Residency at The Veterans Affairs Medical Center in Huntington, West Virginia. Subsequently, he completed a Family Medicine Residency at The University of Florida. Dr. Taylor serves as the Director of the Professional Practice Skills Lab series for The UF College of Pharmacy and also coordinates the third year lab courses. He also is responsible for oversight of the third and fourth year OSCEs. Dr. Taylor currently serves as the Pharmacy Director for the UF and Shands Anticoagulation Clinic. In past years he practiced in a family practice clinic and served as residency director for an Ambulatory Care Residency. Dr. Taylor has had an active role in the Laboratory Instructors SIG since 2016, serving as chair of the mentoring and networking committee for the past three years. He has presented at the AACP Annual Meeting on Lab SIG topics as well as lead Lab SIG webinars. He has given numerous other professional presentations on diabetes, anticoagulation and other primary care topics. He has also published extensively on primary care topics and educational topics such as OSCEs. Finally, he has served as Principal Investigator and Co-Principal Investigator for a number of clinical trials. Current research interests include assessing APPE readiness and anticoagulation. Finally, he is a certified diabetes educator and board certified ambulatory care pharmacist.
Katie Vogel Anderson Pharm.D., BCACP, FCCP
After completing a primary care pharmacy residency, Dr. Vogel Anderson worked as a clinical pharmacy specialist at the Malcom Randall Veterans Affairs Medical Center, where she specialized in anticoagulation management. She held this position for five years, before transferring to the VA geriatric primary care clinic, where she managed anticoagulation, hypertension, diabetes, and other chronic conditions, as part of a multi-disciplinary health care team. Since 2005, Dr. Vogel Anderson has precepted UF pharmacy students on their ambulatory care rotation. In 2010, she joined the faculty full time in the Department of Pharmacotherapy and Translational Research; she has a joint appointment in the UF College of Medicine. Currently, Dr. Vogel Anderson practices at UF Health Internal Medicine at the Medical Plaza. Her research interests include anticoagulation therapy, pharmacist/physician collaboration, and improving medication management at each patient care transition. In 2012, she established the first ASHP accredited PGY1 pharmacy residency program at the UF COP, for which she serves as program director. Dr. Vogel Anderson is faculty advisor for the UF student ACCP chapter, is co-advisor for KE, and served as chair of the UF Faculty Senate in 2018-2019. In 2009, Dr. Vogel Anderson and her husband, Shawn Anderson, established the endowed Vogel/Anderson Exceptional Leader Scholarship for third year pharmacy students. In her free time, Dr. Vogel Anderson likes to attend Gators events and go RV’ing with Shawn and their dogs, Teddie Roosevelt and Johnnie Adams.
Karen Whalen Pharm.D., BCPS, FAPhA
Karen Whalen received her Doctor of Pharmacy degree with highest honors from the University of Florida. She completed a Pharmacy Practice Residency at the Moses Cone Health System followed by a Primary Care Residency at the James A. Haley Veterans’ Hospital. Following residency training, Dr. Whalen was a faculty member in the Department of Pharmacy Practice at Nova Southeastern University (NSU) for 12 years. While at NSU College of Pharmacy, she was an eight-time recipient of the Golden Apple Award for Teaching Excellence. In 2008, Dr. Whalen joined the faculty of the University of Florida College of Pharmacy as assistant director of the St. Petersburg Campus. In 2010, she transitioned to the main campus in Gainesville. She now serves as the Assistant Dean for Curricular Affairs and a Clinical Professor in the Department of Pharmacotherapy and Translational Research. Her excellence in teaching has been recognized with the Faculty Recognition Award in 2011 and 2012, and the Teacher of the Year Award in 2013.
Dr. Whalen is a Board Certified Pharmacotherapy Specialist. She has practiced ambulatory care pharmacy in a variety of settings including an academic family medicine center, community pharmacy practice, and a Veterans’ Affairs Healthcare System. Dr. Whalen is active in local, state and national pharmacy organizations, and is a Fellow of the American Pharmacists Association and a past president of the Florida Pharmacy Association. She is a past recipient of the National Community Pharmacists Association Pharmacy Leadership Award, and the Florida Pharmacy Association Jean Lamberti Mentorship Award.
Chardaè L Whitner Pharm.D.
Dr. Chardaè Whitner joined the University of Florida College of Pharmacy at the Jacksonville Campus in 2021 as a clinical assistant professor. She also serves as the Jacksonville Campus Coordinator for the Office of Diversity, Inclusion and Health Equity. Whitner received her Bachelor of Science from the University of South Carolina and Doctor of Pharmacy degree from Lake Erie College of Osteopathic Medicine. Following graduation, she pursued postgraduate training, completing a community-based pharmacy residency with the University of Florida College of Pharmacy in Jacksonville.
Whitner’s professional areas of interest include diversity, inclusion, health equity, bias, mitigating health disparities among underserved populations, improving health literacy, in addition to increasing cultural awareness and appropriateness among health care professionals.
In her free time, Whitner enjoys spending time with her husband, two children and traveling.
Kristin Wiisanen Pharm.D., FAPhA, FCCP
Kristin Wiisanen received her PharmD from the University of Florida in 1998 and completed residency training at the Medical College of Virginia. Dr. Wiisanen is a Clinical Professor and Associate Dean for Entrepreneurial Programs in the UF College of Pharmacy. She is Associate Director of the University of Florida Health (UF Health) Precision Medicine Program and Director of the Graduate Program in Precision Medicine. Dr. Wiisanen leads clinical and educational efforts for pharmacogenomics in the UF Health Precision Medicine Program and serves as Residency Program Director for an accredited postgraduate Clinical Pharmacogenetics Residency and Director of the Clinical Fellowship in Pharmacogenomics program. She is Editor-in-Chief of Pharmacy Today for the American Pharmacists Association (APhA), a fellow of APhA and the American College of Clinical Pharmacy, and a University of Florida Entrepreneurial Faculty Fellow.
Division of Health-System Based Pharmacotherapy
Kalen Manasco Pharm.D., BCPS, FCCP, FPPAG
Kalen Manasco received a B.S. degree in microbiology and a Pharm.D. degree from the University of Georgia. After graduation, she completed a pharmacy practice residency at Shands Hospital at the University of Florida in Gainesville, Florida, and a pediatric specialty residency at the Medical University of South Carolina in Charleston, South Carolina. She served as a clinical associate professor at the University of Georgia College of Pharmacy from 2007-2017, where she also served as the PGY2 pediatric pharmacy residency program director. From 2003-2007, she served as a clinical assistant professor in the department of clinical and administrative sciences at Mercer University College of Pharmacy and Health Sciences in Atlanta, Georgia. Manasco joined the University of Florida College of Pharmacy in March 2017, as a clinical professor in the department of pharmacotherapy and translational research. She is also a clinical pharmacist with UF Health Shands Children’s Hospital in the pediatric intensive care unit. Her research interests include pediatric infectious disease and pediatric pulmonology (cystic fibrosis and asthma). Manasco is a board certified pharmacotherapy specialist, chair of the ACCP Pediatric Practice and Research Network, and co-series editor for the pediatric pharmacotherapy self-assessment program.
Renad Abu-Sawwa Pharm.D. BCPPS
Dr. Renad Abu-Sawwa is a Clinical Assistant Professor in the Department of Pharmaceutical and Translational Research at the University of Florida College of Pharmacy. She is also one of the Pediatric Intensive Care (PICU) Clinical Pharmacy Specialists at the UF Health Shands Children’s Hospital. She serves as a clinical preceptor at her practice site for PGY-2 and PGY-1 pharmacy residents and fourth-year Doctor of Pharmacy students.
Renad graduated from the University of Florida with both a Bachelors in Food Science and Human Nutrition with an emphasis in Human Nutrition and Doctor of Pharmacy. She completed a PGY-1 Pharmacy Practice Residency at Golisano Children’s Hospital at the University of Rochester Medical Center in Rochester, New York. During her PGY-1 year she completed a teaching certificate at St. John Fisher College, Wegmans School of Pharmacy. Following her PGY-1, Renad went on to Texas Children’s Hospital in Houston, Texas for her PGY-2 Pediatric Pharmacy Residency. Before joining UF in 2021, she was a Clinical Assistant Professor at the University of Georgia, where she developed a new practice site in the Pediatric Neurology/Epilepsy Clinic at Children’s Hospital of Georgia at the Augusta University Medical Center and served as a clinical preceptor for pharmacy residents and students.
Renad is a member of the American Association of Colleges of Pharmacy (AACP) American College of Clinical Pharmacy (ACCP), and Phi Lambda Sigma Pharmacy Leadership Society (PLS). She also is an active member of Pediatric Pharmacy Association (PPA) and is the founder/chair of their Neurology Special Interest Group.
Kaitlin M Alexander Pharm.D.
Kaitlin Alexander, Pharm.D. is a Clinical Associate Professor in the Department of Pharmacotherapy and Translational Research. Dr. Alexander joined the University of Florida faculty in May 2021 and maintains a clinical practice in the trauma intensive care unit at UF Health Shands Hospital in Gainesville, Florida.
Dr. Alexander graduated from the University of Florida with her Doctor of Pharmacy degree in 2012. She then completed a PGY-1 Pharmacy Practice Residency at West Virginia University Healthcare, followed by a PGY-2 Residency specializing in critical care at Wake Forest Baptist Medical Center. Prior to her appointment at the University of Florida, she was an Associate Clinical Professor at the Auburn University Harrison College of Pharmacy from 2014-2021.
Dr. Alexander is an active member of the Society of Critical Care Medicine (SCCM), the American Association of Colleges of Pharmacy, and the American College of Clinical Pharmacy (ACCP). Her professional interests, include: the management of pain, agitation and delirium in the ICU, infectious diseases, optimization of venous thromboembolism prophylaxis, and trauma & acute care surgery critical care management.
John M Allen Pharm.D., BCPS, BCCCP, FCCM, FCCP
John M. Allen, Pharm.D., BCPS, BCCCP, FCCM, FCCP is the UF College of Pharmacy’s associate dean for diversity, inclusion and health equity and a clinical associate professor at the college’s Orlando campus. Born and raised in Philadelphia, Dr. Allen joined the college in 2018. Dr. Allen’s professional areas of interest include health equity, antimicrobial stewardship in the intensive care unit, antibiotic dosing in sepsis, and treatment of multi-drug resistant infections in critically ill patients.
Dr. Allen graduated with his Doctor of Pharmacy degree from Florida A&M University in Tallahassee, FL. He then completed a PGY-1 residency, followed by a PGY-2 Critical Care residency at Tampa General Hospital, in Tampa, FL. Dr. Allen is a dual board-certified pharmacist in critical care, and pharmacotherapy.
Dr. Allen is an active member of the Society of Critical Care Medicine, American College of Clinical Pharmacy, Society of Infectious Diseases Pharmacists and the Florida Society of Health-System Pharmacists and has been appointed to committees within all of these organizations. In 2017, Dr. Allen received the prestigious honor of induction as a Fellow of the American College of Critical Care Medicine, which honors individuals whose achievements and contributions demonstrate personal commitment to critical care excellence, a distinction at the time of his induction bestowed upon seven pharmacists in the state of Florida.
Prior to his appointment at the University of Florida, Dr. Allen has held a variety of diverse administrative experiences including serving as a pharmacy clinical coordinator, pharmacy residency program director, and director of infectious diseases pharmacy for a 16-hospital system. In his free time, Dr. Allen enjoys watching anything with four wheels going fast, traveling, and spending time with his wife and three children.
Shauna Buring Pharm.D.
Shauna Buring, Pharm.D., assumed the leadership role as associate dean for student affairs in May 2016, and in July 2018, she moved into her current position as Associate Dean for Professional Education.
Buring joined UF following 14 years at the University of Cincinnati James L. Winkle College of Pharmacy, her alma mater. She most recently served as associate dean for professional education and assessment where she helped UC secure an eight-year accreditation from the Accreditation Council for Pharmacy Education. In addition, she has led many curricular improvements, including the development of new pharmacy practice skills lab courses and a teaching certificate program for first-year pharmacy residents in the Cincinnati area. Prior to her work at UC, Buring was an assistant professor at Auburn University Harrison School of Pharmacy.
With the appointment, Buring returned to Florida where she started her professional pharmacy career as a staff pharmacist at Lee Memorial Hospital in Fort Myers from 1991-94. Additionally, she completed a drug information specialty residency at Shands Hospital in Gainesville in 1997.
Anthony M Casapao Pharm.D., M.P.H.
Anthony M. Casapao received his Doctor of Pharmacy degree from Wingate University in Wingate, North Carolina. He then pursued post-graduate training at St. Vincent’s Medical Center in Jacksonville, Florida, by completing an American Society of Health-System Pharmacists, or ASHP, -accredited pharmacy practice residency. Casapao continued his post-graduate training at University of Pittsburgh Medical Center in Pennsylvania, completing an ASHP-accredited specialty practice residency in infectious diseases. Upon completion of his residency, he maintained his interest in infectious diseases and pursued an American College of Clinical Pharmacy peer reviewed pharmacotherapy fellowship in infectious diseases and health outcomes. After achieving five years post-graduate training, Casapao served as an assistant professor in the department of pharmacy practice at Husson University School of Pharmacy in Bangor, Maine. Casapao joined the University of Florida in October 2017, as a clinical assistant professor in the department of pharmacotherapy and translational research. He was promoted to clinical associate professor in 2022.
Lindsey Childs-Kean Pharm.D., M.P.H., BCPS
After completing her Pharm.D. from the University of Florida College of Pharmacy, Dr. Childs-Kean completed a PGY-1 residency at Tampa General Hospital in Tampa, FL, followed by a PGY-2 residency in Infectious Diseases Pharmacy at the South Texas Veterans Affairs Healthcare System in San Antonio, TX. Prior to joining UF full-time, she was the Hepatology Pharmacy Program Manager at Bay Pines VA Healthcare System in Bay Pines, FL. In that role, she established a pharmacist-led Hepatitis C clinic for patients throughout the Bay Pines System, including patients seen using Clinical Video Telehealth technology. Her professional interests include infectious diseases pharmacotherapy as well as professional development of students and new practitioners. Dr. Childs-Kean is active in many professional organizations at the state and national level, including the American Society of Health-System Pharmacists and the Florida Society of Health-System Pharmacists.
Randell E Doty Pharm.D.
Dr. Doty received a Doctor of Pharmacy degree from the University of Tennessee in 1988 and completed a general clinical residency at the Veterans Administration Medical Center in Memphis Tennessee in 1989. He accepted an appointment in the Department of Pharmacy Practice at the University of Florida in 1989 and served as Associate Director of the Computer Applications in Pharmacy Center until it closed in 1991. Dr. Doty is a Clinical Associate Professor in the Department of Pharmacotherapy and Translational Research. He served for more than 20 years as director of Experiential Programs at the University of Florida College of Pharmacy and currently co-coordinates the Pathophysiology and Patient Assessment course sequence in the first year. He also teaches in the skills lab, instructs students in their immunization training and practices in the UF Health adult Emergency Department.
Carinda J Feild Pharm.D.
Dr. Feild earned her Pharm.D. degree from the University of Florida in 1989. She then completed an ASHP accredited two-year residency with emphasis in critical care at the University of Kentucky and a two-year critical care fellowship at the University of Kentucky’s Drug Product Evaluation Unit. She joined UF College of Pharmacy faculty in 2010 as a Clinical Associate Professor and previously served as Assistant Dean and Campus director for the St Pete Campus. She currently serves as Assistant Director for the Office of Experiential Programs.
Prior to taking this position, she worked at the R Adams Cowley Shock Trauma Center / University of Maryland Medical Center for seven years. For the last four of those years she served as the critical care research section manager and a clinical research pharmacist. For the 10 years prior she worked as a clinical pharmacy specialist in critical care caring for surgical, cardiothoracic, and trauma patients and teaching pharmacy students at Boston University Medical Center, Orlando Regional Healthcare System where she also served as the Clinical Coordinator, and Keesler Air Force Base Medical Center where she was also involved in research. She has been an Assistant Professor with the University of Florida’s Working Professional Pharm.D Program since 1997. She started as an Orlando site facilitator and has also served as the regional director, a course coordinator and advisor, a pharmaceutical care project reviewer, and currently works on special projects. She was awarded the Air Force Clinical Research Award for work done at Keesler in 2001 and she was the Spring 2007 recipient of the Faculty Service Award for the WPPD program.
Adonice Khoury Pharm.D., BCPS
Adonice Khoury is a Clinical Associate Professor in the Department of Pharmacotherapy and Translational Research and Clinical Specialist in Internal Medicine at UF Health/Shands Hospital. Dr. Khoury received a B.S. in Microbiology & Cell Science from the UF College of Agriculture and a Doctor of Pharmacy degree from the UF College of Pharmacy. He also completed an ASHP accredited specialty residency in Geriatric pharmacy practice at the Malcom Randall VA Medical Center in Gainesville. Prior to joining the college, Dr. Khoury was the head clinical pharmacist and antimicrobial stewardship pharmacist for six years at Select Specialty Hospital in Gainesville, a 44-bed long-term acute care hospital. Dr. Khoury was active with the college at Select Specialty Hospital, serving as a preceptor for adult medicine APPE rotations. His primary clinical practice and research interest is in internal medicine with specific interests in the subspecialties of gastrointestinal and infectious diseases pharmacotherapy.
Kayihura Manigaba Pharm.D., BCIDP
Dr. Kayihura Manigaba received his doctor of pharmacy degree from the University of Tennessee College of Pharmacy in Memphis, TN. He then completed an ASHP-accredited PGY-1 Pharmacy Residency, followed by an ASHP-accredited PGY2 Residency in Infectious Diseases at UF Health Shands Hospital in Gainesville, Florida. In December 2021, Dr. Manigaba joined the University of Florida College of Pharmacy from North Florida Regional Medical Center (NFRMC), where he was an Advanced Clinical Pharmacist in Infectious Diseases and, most recently, a Clinical Pharmacy Manager. While at NFRMC, Dr. Manigaba contributed to the UF College of Pharmacy program by teaching in the Patient Care 2 course and precepting APPE students. Dr. Manigaba is board certified in infectious diseases pharmacy, and his professional and research areas of interest include infectious diseases, therapeutic drug monitoring, treatment of multidrug-resistant pathogens, and antimicrobial stewardship. He is a member of the American Society of Health-System Pharmacists and the American College of Clinical Pharmacy.
Priti Patel Pharm.D.
Dr. Patel completed and ASHP-accredited drug information residency at the Thomas Jefferson University Hospital in Philadelphia and McNeil Consumer and Specialty Pharmaceuticals in Fort Washington, PA. Prior to joining UF, she was an associate clinical professor at St. John’s University College of Pharmacy and Allied Health Professions, and co-director of the St. John’s University drug information service at Long Island Jewish Medical Center.
At the University of Florida College of Pharmacy, Dr. Patel serves as Director of Personal and Professional Development, overseeing the series of 9 PPD courses in the PharmD curriculum. Her areas of teaching in the PharmD program include evidence-based practice and women’s health.
Barbara Santevecchi Pharm.D., BCPS, BCIDP
Barbara Santevecchi joined the College of Pharmacy as a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research in August 2019. She serves as an Infectious Diseases Clinical Specialist and member of the Antimicrobial Management Program at UF Health Shands Hospital. She received her Doctor of Pharmacy degree from Wingate University School of Pharmacy in Wingate, North Carolina in 2015. Following graduation, she completed PGY1 Pharmacy Practice and PGY2 Infectious Diseases pharmacy residencies at the Medical University of South Carolina in Charleston, South Carolina. After completing residency training, she worked as an Infectious Diseases Clinical Pharmacist at Atrium Health in Charlotte, North Carolina. Barbara holds dual board certification in pharmacotherapy and infectious diseases. Her research interests include HIV/AIDS, microbiology, rapid diagnostics, novel agents for multidrug resistant infections, and antimicrobial stewardship. Barbara has published research in several peer-reviewed journals and has delivered presentations on her research at national meetings.
Bethany R Shoulders Pharm.D., BCCCP
Bethany Shoulders, Pharm.D., joined the College of Pharmacy as a clinical assistant professor in the department of pharmacotherapy and translational research in July 2016. She maintains a clinical practice site at the trauma ICU at UF Health Shands Hospital.
Shoulders received her Pharm.D. degree from the University of Tennessee Health Science Center in 2014. She then completed a pharmacy practice residency at The Johns Hopkins Hospital in Baltimore and travelled to Pittsburgh to complete her PGY2 critical care pharmacy practice residency with the University of Pittsburgh Medical Center. Her research endeavors during residency included evaluating intraoperative continuous infusion cefazolin in a cardiac surgery population and characterizing the guideline evidence behind off-label medication use in the intensive care unit.
Lisa Vandervoort Pharm.D.
Lisa Vandervoort received her Doctor of Pharmacy degree from the University of Florida College of Pharmacy in 1995 and completed a Pharmacy Practice Residency at Shands Hospital at the University of Florida in 1996. She spent 10 years as the Clinical Specialist in Infectious Disease/Internal Medicine at Orlando Regional Medical Center. She joined the faculty at the University of Florida College of Pharmacy Orlando Campus in 2007. Through coordinating the Advanced Pharmacy Practice Experience (APPE) Readiness course, the Hospital Introductory Pharmacy Practice Experience (HIPPE) course, and 2PD Skills Lab for the Orlando campus, as well as her work as a Regional Coordinator for the Office of Experiential Programs, Dr Vandervoort’s focus is on preparing students for pharmacy practice. Her interests include APPE Readiness, Professional Identity Formation, and Infectious Disease.
Veena Venugopalan Pharm.D.
Veena Venugopalan received her Doctor of Pharmacy degree from the University of Kentucky College of Pharmacy. Following graduation, she completed her pharmacy practice residency and infectious diseases specialty residency at the University of Kentucky Medical Center. As a board certified pharmacist with added qualifications in infectious diseases pharmacotherapy, Venugopalan has developed and maintained antimicrobial stewardship programs at large academic centers as well as community teaching hospitals. She joined the faculty at the University of Florida College of Pharmacy as an assistant professor in January 2016. She serves as the infectious diseases clinical specialist at UF Health Shands Hospital. Her research and patient care activities focus on health care associated infections, multidrug resistant gram-negative infections and antimicrobial stewardship. Her work has been published in peer-reviewed journals, and she has been presented at national and international conferences.
Division of Translational Research
Charles Peloquin Pharm.D.
Prior to coming to the University of Florida, Dr. Peloquin completed a hospital pharmacy residency at Duke University Medical Center, where he also served on the clinical staff. He also completed a fellowship in Infectious Diseases and Pharmacokinetics at the Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital, Buffalo, N.Y. For 20 years, Dr. Peloquin was the Director of the Infectious Disease Pharmacokinetics Laboratory (IDPL) at National Jewish Health, Denver, CO. He now serves as Professor of Pharmacy and Medicine at UF, where the IDPL now is located. Dr. Peloquin and his lab are part of the UF Emerging Pathogens Institute. He has served a consultant to the FDA, CDC and WHO, and has contributed to national guidelines on the treatment tuberculosis and the treatment of opportunistic infections in patients living with AIDS.
Mohammad H Alshaer Pharm.D., Ph.D.
Dr. Alshaer is a Research Assistant Professor at the Infectious Disease Pharmacokinetics Laboratory, Department of Pharmacotherapy and Translational Research, UF College of Pharmacy. Dr. Alshaer received a Pharm.D. from Jordan University of Science and Technology and a Ph.D. from University of Florida. He worked as a clinical specialist for years, then joined UF College of Pharmacy. His research focuses on the pharmacokinetics/pharmacodynamics of antimicrobial therapy in patients with serious infections with special interest in beta-lactams, population pharmacokinetics, precision dosing, and antimicrobial exposure-response relationship in patients.
Jürgen Bulitta Ph.D.
Jürgen B. Bulitta, PhD, is a professor in the Department of Pharmacotherapy and Translational Research at the UF College of Pharmacy. He is supported by the University of Florida’s preeminence program in Drug Discovery and Development, and received the Perry E. Foote Eminent Scholar Chair, Endowed Professorship, in 2019. Dr. Bulitta’s research focuses on combating multidrug-resistant bacterial ‘superbugs’ which present one of the three most serious threats to human health.
His mission is to optimize patient therapies and innovative drug development by providing a focal point for translational research in infectious diseases and related areas, and to serve as an internationally-leading, interdisciplinary, collaborative program for translational research.
Dr. Bulitta’s vision is to provide novel solutions and great hope for patients with serious, life-threatening infections by developing new safe and effective therapies. These are informed at the molecular level by an innovative combination of mechanistic, in vitro, animal and quantitative approaches to rationally optimize outcomes in patients. His highly collaborative research program leverages latest pharmacological, microbiological, biochemical and computational approaches. This creates unique translational insights that enable novel therapies and dosing strategies, as well as the design and development of new drugs. We work hard so that we can say “we have an effective therapy for you” when you most need it.
He won 26 peer-reviewed grants (15 as PI) from the NIH, FDA, the Australian equivalents of NIH and NSF, as well as 30 collaborative projects with pharmaceutical industry (total: $35M, 18M active). Dr. Bulitta published 140 peer-reviewed papers and contributed to over 97 phase I-IV clinical trials. He reviewed for several NIH study sections and received 23 awards since 1998. These include the Giorgio Segré Prize 2010 for distinct contributions in the field of pharmacokinetics and pharmacodynamics by the European Federation for Pharmaceutical Sciences (EUFEPS) and the 2012 ASCEPT Denis Wade Johnson & Johnson New Investigators Award. Dr. Bulitta created the Translational Clinical Pharmacology course (PHA6133). He is the creator and developed of the SADAPT-TRAN package that greatly facilitates the development of systems pharmacology models in the S-ADAPT population modeling package.
Larisa H Cavallari Pharm.D., BCPS, FCCP
Dr. Cavallari received her B.S. Pharmacy and Pharm.D. degrees from the University of Georgia. She then completed a Pharmacy Practice Residency at the Veterans Affairs Medical Center in Memphis, Tennessee and a fellowship in Cardiovascular Pharmacogenomics at the University of Florida. Dr. Cavallari accepted a position as an Assistant Professor of Pharmacy Practice at the University of Illinois at Chicago after completing her training and was promoted to Associate Professor in 2009. While at UIC, she directed efforts to implement genotype-guided warfarin dosing for all patients newly starting warfarin during hospitalization. Dr. Cavallari joined the University of Florida Department of Pharmacotherapy and Translational Research as an Associate Professor in April, 2014, where she serves as director of the Center for Pharmacogenomics and Precision Medicine. She also serves as Director of the UF Health Precision Medicine Program. In 2021, she was promoted to professor. Her research involves discovery and clinical translation of genetic variants related to drug response and has been funded by the NIH, FDA, American Heart Association, and other awards.
Dr. Cavallari has served on both NIH and American Heart Association grant review committees and is a Board Certified Pharmacotherapy Specialist, Fellow of the American College of Clinical Pharmacy, former Chair of the American College of Clinical Pharmacy Research Institute, and Editorial Board Member for the Lexi-Comp pharmacogenetics series.
Rhonda M Cooper-DeHoff Pharm.D., M.S., FAHA, FACC, FCCP
Dr. Cooper-DeHoff is a Associate Professor in the Department of Pharmacotherapy and Translational Research, and the Department of Pharmaceutics in the College of Pharmacy, and in the Division of Cardiovascular Medicine, College of Medicine at the University of Florida.
David DeRemer Pharm.D., BCOP, FCCP, FHOPA
David DeRemer received his B.S. Biology and Pharm.D. degrees from the University of Kentucky. Following graduation, he completed a Pharmacy Practice Residency and an Oncology specialty residency at the University of Kentucky Chandler Medical Center. He followed that with an Oncology Postdoctoral Fellowship focusing on Drug Discovery/Development at the University of Kentucky. DeRemer is a fellow of the American College of Clinical Pharmacy (ACCP) and the Hematology Oncology Pharmacist Association (HOPA). He is currently the President-Elect for HOPA and actively participates in multiple HOPA committees. He joined the University of Florida College of Pharmacy in September 2017 and is actively participating in early phase UF Health Cancer Center clinical trials.
Julio D Duarte Pharm.D., Ph.D., FAHA
Julio Duarte is an associate professor in the Department of Pharmacotherapy and Translational Research and Associate Director of the UF Center for Pharmacogenomics and Precision Medicine. He received his Pharm.D. as well as his Ph.D. in clinical pharmaceutical sciences from the University of Florida. He was Assistant Professor of Pharmacy Practice at the University of Illinois at Chicago (UIC) until returning to UF in 2015. While at UIC, Dr. Duarte was Co-Director of the University of Illinois Hospital Personalized Medicine Program. Dr. Duarte has served as a reviewer for both NIH and U.S Department of Defense study sections. He is also an elected fellow of the American Heart Association and has received awards for his research from both UIC and UF. Dr. Duarte also serves as graduate coordinator of the Clinical Pharmaceutical Sciences concentration within the College of Pharmacy’s graduate program.
Reginald Frye Pharm.D., Ph.D., FCCP
Reginald Frye, Pharm.D., Ph.D., is the UF College of Pharmacy’s associate dean for faculty development and a professor and chair for the department of pharmacotherapy and translational research. He received a B.S. in Biology from Oglethorpe University, a Pharm.D. from Mercer University School of Pharmacy, and a Ph.D. in Clinical Pharmaceutical Sciences from the University of Pittsburgh School of Pharmacy. After completing graduate work, Dr. Frye remained on faculty at the University of Pittsburgh from 1995 until 2003, being promoted to Associate Professor with tenure in 2002. He joined the faculty at the University of Florida in July 2003 and in July 2012, he was promoted to Professor.
Yan Gong Ph.D.
Yan Gong, Ph.D., is an Associate Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida (UF) College of Pharmacy and the UF Center for Pharmacogenomics and Precision Medicine. Dr. Gong received a Ph.D. in Pharmaceutics in 2004 from Department of Pharmaceutics, College of Pharmacy at UF. She also obtained a Master’s Degree in Statistics in 2003 from UF Department of Statistics. Before joining the UF faculty in 2005, she completed one year of post-doctoral Fellowship in Cardiovascular Pharmacogenomics at the UF Center for Pharmacogenomics.
Dr. Gong’s research focuses on pharmacogenomics of efficacy and adverse response of antihypertensives medications, and pharmacogenomics of serious adverse drug events such as medication-related osteonecrosis of the jaw (MRONJ) and cardiotoxicities related to cancer therapies (Cardio-Oncology). Dr. Gong has authored over 170 peer-reviewed publications.
In addition to research, Dr. Gong has been involved in teaching multiple graduate level and professional level courses at the UF College of Pharmacy and College of Medicine. She is currently the course co-coordinator for Pharmacogenomic and Genomic Data Analysis (PHA6449), a required graduate level course for the Department of Pharmacotherapy and Translational Research at the UF College of Pharmacy.
Julie A Johnson Pharm.D.
Julie A. Johnson, Pharm.D., is a distinguished professor of Pharmacy and Medicine at the University of Florida. She previously served as dean of the UF College of Pharmacy from 2013 until 2022. She received her B.S. in Pharmacy from the Ohio State University and her Pharm.D. from the University of Texas at Austin and the UT Health Science Center at San Antonio. She completed a post-doctoral fellowship in cardiovascular pharmacology/pharmacokinetics at Ohio State.
Johnson’s research focuses on cardiovascular pharmacogenomics and genomic medicine implementation. She is an internationally-recognized leader in pharmacogenomics and genomic medicine, with over 300 peer reviewed publications and nearly $50 million in research funding as principal investigator. In 2015, 2016, 2017 she was named a Thomson Reuters (now Clarivate Analytics) Highly Cited Scientist in Pharmacology and Toxicology, and in 2018 in the Cross Discipline category, indicating she is in the top 1% of the most highly cited scientists in the field globally.
Johnson has served on the Nonprescription Drugs Advisory Committee of the FDA, the XNDA Study Section at NIH, and in numerous scientific capacities with NIH’s NHLBI. She has had leadership roles in the American College of Clinical Pharmacy (ACCP), the American Heart Association (AHA), and the American Society of Clinical Pharmacology and Therapeutics (ASCPT), for which she completed her term as President in 2017. She is an elected fellow of the ACCP, the AHA and the American College of Clinical Pharmacology (ACCP-Pharmacology). Johnson was elected to the National Academy of Medicine (formerly Institute of Medicine) in 2014 and has received numerous other awards including teaching awards from both the University of Tennessee (1996) and the University of Florida (2001); the Ohio State University Alumni Association William Oxley Thompson Award for early career achievement (1997), Leon I Goldberg Young Investigator Award from the ASCPT (2004), Paul Dawson Biotechnology Research Award, American Association of Colleges of Pharmacy (AACP) (2007), Therapeutic Frontiers Award (2009) and Russell R Miller Award for Contributions to the Literature (2010), both from ACCP, the Southeastern Universities Research Association Distinguished Scientist Award (2015); AACP Volwiler Research Achievement Award (2016), the ACCP-Pharmacology Distinguished Scientist Award (2019), the ACCP Paul Parker Medal (2019), elected fellow of the American Association for the Advancement of Science (2020), the Rawls Palmer Progress in Medicine Award from the American Society for Clinical Pharmacology and Therapeutics (2021), and the Precision Medicine World Conference Luminary Award recipient (2021), among others.
Jatinder Lamba Ph.D., M.Sc.
Dr. Jatinder Lamba is currently Professor in the Department of Pharmacotherapy and Translational Research. She did her post-doctoral training at St. Jude Children’s Research Hospital in Memphis, Tennessee. Prior to joining University of Florida, she was an Associate Professor at University of Minnesota, Department of Experimental and Clinical Pharmacology, College of Pharmacy and the Director of the Pathway driven Pharmacogenomics; University of Minnesota Alliance (PUMA) Institute of Personalized Medicine.
Dr Lamba’s research is focused on identification, characterization and clinical validation of genomic/epigenomic markers predictive of therapeutic outcome in cancer patients. This research spans from preclinical basic research comprising the discovery phase utilizing cell line model systems to translational/clinical phase in patient populations from multi-institute clinical trials. The long-term goal of her research is to move pharmacogenetic testing into the clinical setting to improve safety and efficacy of drug therapy. Dr. Lamba’s research on pharmacogenomics of anti-leukemic agents has been funded by NIH/NCI since 2008. Specifically, her current NCI funded R01 focuses on pharmacogenomics/ epigenomics of cytarabine (ara-C), a nucleoside analog that is the backbone of anti-leukemia chemotherapy in pediatric AML patients. Her group is working on developing algorithms to incorporate pharmacogenomics/epigenomic markers with other prognostic factors to advance precision medicine in oncology. Identification of such patients upfront will provide opportunity to tailor the initial chemotherapy to achieve maximum benefit.
Dr. Lamba’s lab is the first one to identify genetic polymorphisms in CD33 gene that are predictive of response to CD33 targeted agents in AML. These results hold promise in utilizing preemptive genotype to select patients most likely to benefit from CD33-directed therapy such as gemtuzumab ozogamicin in treating AML. Previous work on CD33 genomics was funded by NCI and more in-depth characterization of CD33 as AML therapeutic target is funded by a recent award from leukemia Lymphoma Society.
Given a critical gap of our understanding in metabolic dysregulation in AML, Dr. Lamba’s group is focused understanding the metabolomics differences and biomarkers of prognostic significance in pediatric AML. Dr. Lamba’s recent work is focused towards utilizing transcriptomics to build and refine leukemic stem cell signatures and AML drug response signatures of prognostic and predictive value in AML.
Dr. Lamba has served as chair of Pharmacogenomics SIG at AACP (2013) and is currently vice-chair of Pharmacogenomics focus group with AAPS. She has served as a grant reviewer for numerous NIH study sections and has reviewed grants for international agencies as Italian Ministry of Health. She has published more than 90 research articles in peer-reviewed journals and is on the editorial boards of Leukemia and Lymphoma, Pharmacogenomics and Frontiers in Pharmacogenomics and genomics, JCMM. Dr. Lamba is currently Professor in College of Pharmacy and is also Graduate Program coordinator for PTR department. Dr. Lamba is very committed towards training of future generation of scientist. She has trained 6 Ph. D students, 5 Post-doctoral fellows several Pharm D students and 3 hematology-oncology fellows and several under-graduate students including minority and underrepresented students.
Yinzhi Lang Ph.D.
Yinzhi Lang, PhD, is a Research Assistant Professor in the Department of Pharmacotherapy and Translational Research at the UF College of Pharmacy. Dr. Lang’s research focus on developing novel assays and elucidating the mechanism of drug action and resistance via LC-MS and QSP modeling approach.
Dr. Lang completed her PhD program in 2016 from Ocean University of China. For her doctoral research, she developed advanced biochemical and bioanalytical methods for extracting and analyzing complex biological macromolecules (glycans, proteoglycans, glycoproteins and glycolipids) from various tissues of plants, animals and humans. Between 2016 and 2018, Dr. Lang worked as a senior Scientist in Shanghai Greenvalley Pharmaceutical Co.Ltd. She played an integrated role on developing instrumental analysis methods (LC-MS, CE-MS & GC-MS) for QC and ADME study of an innovative anti-Alzheimer agent GV-971 (Phase III, NCT04520412).
In 2018, Dr. Lang joined the College of Pharmacy at UF as a Postdoc and has received systematic training in antimicrobial pharmacology, pharmacokinetics and pharmacodynamics from Dr. Bulitta and his collaborators. She has created a series of UPLC-MRM-MS/MS assays to quantify the target site penetration of antibacterial in Gram-negative bacteria, and accumulation of antiviral drugs in mammalian cells. Moreover, she employed LC-MS/MS based proteomics, metabolomics and lipidomics to characterize microbial biomolecules. In 2021, Dr. Lang was appointed as a Research Assistant Professor in the college. She is now significantly contributing to the development of Quantitative and Systems Pharmacology (QSP) models with Dr. Bulitta, which can integrate these mechanistic data with pathogen killing, resistance, tolerance and persistence to rationally optimize anti-infective therapy. Dr. Lang is leading several funded anti-infection projects to create novel insights to combat serious infections.
Taimour Langaee MSPH, Ph.D.
Dr. Langaee is a Research Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida (UF) College of Pharmacy and Director of the UF Center for Pharmacogenomics Genotyping Core Laboratory. Before joining the UF faculty in 2002, he completed three years of post-doctoral fellowship in Immunology and Molecular Biology, and Microbiology and Molecular Genetics working on developing HIV vaccine at the College of Medicine University of Montreal and High Density DNA chips for Pseudomonas aeruginosa at the College of Medicine University of Florida.
Dr. Langaee’s research interests are focused on pharmacogenomics (genetic-based variability in drug response) and Precision Medicine, Infectious Disease and Microbial Resistance to Beta-lactam Antibiotics, developing microarray-based technology methods to facilitate disease diagnosis, developing genotype-phenotype translation table, genotyping, and discovering disease-gene associations.
John S Markowitz Pharm.D., BCPP
Dr. Markowitz received his BS in Biology from Memphis State University, and his Doctorate in Pharmacy (Pharm.D.) from the University of Tennessee Center for the Health Sciences (UTCHS). He completed an ASHP-accredited specialty residency in Psychiatric Pharmacy Practice, also at UTCHS. Following his education and training, Dr. Markowitz served for a decade as a Clinical Specialist in Psychiatry, and eventually Clinical Coordinator within the Institute of Psychiatry at the Medical University of South Carolina (MUSC) in Charleston, South Carolina. He eventually transitioned from clinician to a primary faculty research position in the MUSC College of Pharmacy’s Department of Pharmaceutical & Biomedical Sciences with a dual appointment in the Department of Psychiatry and Behavioral Sciences where he had remained prior to joining the UF College of Pharmacy in 2009. Dr. Markowitz has been credentialed by the Board of Pharmaceutical Specialties in Psychiatric Pharmacy (BCPP) since 1997 and is a founding member of the College of Psychiatric and Neurologic Pharmacists (CPNP).
Caitrin W McDonough Ph.D., M.S.
Dr. McDonough received a B.S. in Biochemistry (with a minor in chemistry) from the University of Iowa and then earned a Ph.D in Molecular Medicine and Translational Science from Wake Forest University School of Medicine. After completing graduate studies, she completed a Post-Doctoral Fellowship in Cardiovascular Pharmacogenomics under the direction of Dr. Julie Johnson.
Dr. McDonough is an investigator in the Center for Pharmacogenomics. Her research focuses on identifying and predicting patients at high risk for cardiovascular disease. She uses multiple methods (regression modeling and machine learning) to integrate data from multiple sources (e.g. electronic health records, insurance claims, ‘omics) to identify factors or signatures that are associated with adverse cardiovascular outcomes.
Khoa Nguyen Pharm.D.
Khoa Nguyen, Pharm.D., received his Doctor of Pharmacy degree from the University of Michigan, College of Pharmacy. He then completed a fellowship in medical informatics at the VA Indianapolis, HSR&D. After his fellowship, he joined the Regenstrief Institute, Center for Health Services Research as a research scientist and Purdue University, College of Pharmacy as a Visiting Assistant Professor. Currently, Khoa is a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida, College of Pharmacy. His clinical practice is within the UF Health Personalized Medicine Program to help develop and improve pharmacogenomic clinical decision supports. Dr. Khoa Nguyen’s research interests include human-computer interaction, pharmacogenomics, and health informatics. His research focused on improving patient safety through medication use from two approaches: qualitative research and quantitative research. Using the qualitative research approach, Dr. Nguyen wants to utilize human factor engineering and human-computer interaction method to develop and implement pharmacogenomic clinical decision supports (PGx-CDS). PGx-CDS, when implemented, can foster pharmacogenomics service to predict and prevent severe adverse drug reactions from genetic mutations. Using the quantitative research approach, he wants to identify risk factors that can increase the risk of adverse drug reactions from literature and healthcare organizations’ data. Dr. Nguyen also wants to identify subpopulations that can have genetic testing cost-effectively.
Luisel Ricks-Santi Ph.D.
Dr. Luisel Ricks-Santi is a cancer genomics researcher and population scientist possessing over 15 years of academic research experience. She is committed to diversity & inclusion through research education and training and is particularly adept in the areas of grantsmanship, organizational leadership, clinical-translational methods and transdisciplinary team science approaches.
Dr. Ricks-Santi is a 2000 graduate of Hampton University where she received her Bachelor of Science degree in Cellular and Molecular biology. She also received her PhD from Georgetown University in Tumor Biology and completed two post-doctoral fellowships at Howard University in Cancer Genomics/ Cancer Disparities research, and Clinical-Translational Sciences. Her current research aims to identify the genetic drivers of cancer disparities with a focus on the breast and prostate cancer, two (2) cancers with high mortality rates in the African American community.
In her spare time, Dr. Ricks has been using her cancer biology background in service to her community by educating about cancer screening recommendations, participation in clinical trials and engaging diverse communities precision medicine research. Interacting directly with the community has inspired her to become a greater advocate for cancer screening especially in communities where cancer incidence and mortality is high.
She is a member of Delta Sigma Theta Sorority, Inc. and the The Links, Inc., organizations dedicated to the implementation of programs that impact health disparities in the global community.
Areas of Expertise Cancer Epidemiologist | Population Sciences | Genomics | Genetic Epidemiology | Precision Medicine | Clinical-Translational Medicine | Next Generation Sequencing | Microbiome | Bioinformatics | Biostatistics | Epidemiology | Biospecimen Science |Cancer Genetics & Genomics | Public Health Genomics | Molecular Biology | Health Disparities | Cancer Disparities | STEM Education in Minorities and Women
Nathan D Seligson Pharm.D.
Dr. Seligson earned his Doctor of Pharmacy degree from the University of South Florida prior to completing a pharmacy practice residency. Dr. Seligson then completed a post-doctoral fellowship in translational hematology/oncology focused on precision medicine in sarcoma.
Dr. Seligson is a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research. His clinical practice includes activities as a clinical pharmacogenomics specialist and hematology/oncology research scientist at Nemours Children’s Specialty Care in Jacksonville, Florida.
Dr. Seligson has been published in as first author in leading journals including: JAMA Open Network, The Oncologist, and npj Precision Medicine. His current research includes work to better understand cancer biology and tumor evolution in order to provide actionable molecular subtyping and pharmacogenomic therapy guidance in sarcoma.
Danxin Wang M.D., Ph.D.
Dr. Wang received her MD degree from Fudan University Medical School and her Ph.D from the Academy of Military Medical Science in Beijing. She did postdoctoral training at the University of California San Francisco. She was a Research Assistant Professor at Ohio State University, Department of Cancer Biology and Genetics and Associate Director of Center for Pharmacogenomics prior to joining the University of Florida.
Dr. Wang’s research interests are the discovery of genetic biomarkers for personalized drug therapy. She has discovered many functional regulatory variants in genes related to drug therapy in the areas of cardiovascular diseases, mental diseases and drug dependence. Some of these functional variants are currently included in biomarker testing panels to predict drug response.
Funded by NIH R01 and R35 awards, Dr. Wang’s current research is to understand factors controlling the expression of cytochrome P450 drug metabolizing enzymes (CYPs) in the liver. Using recently developed cutting edge functional genetics/genomics approaches, the research will focus on understanding what genetic, epigenetic and non-genetic factors may contribute to CYPs variability, with the goal to identify biomarker predicting enzyme activity of CYPs for guiding personalized drug therapy.
Dr. Wang has served as an Associate Editor of “European Journal of Pharmaceutical Sciences” and was on editorial Board of “Journal of Pharmacogenomics and Pharmacoproteomics”. She has also served as grant reviewer for NIH.
Diane Beck Pharm.D.
Diane E. Beck, Pharm.D., is a Clinical Professor Emeritus with the Department of Pharmacotherapy and Translational Research in the University of Florida College of Pharmacy. She was previously Associate Dean for Curricular Affairs and Accreditation (2009-2019) and also Clinical Professor at the University of Florida College of Pharmacy (2004-2019). She received her Bachelor of Science and Doctor of Pharmacy degrees from the University of Florida College of Pharmacy (1977 and 1979). She is also Professor Emerita at Auburn University, Harrison School of Pharmacy. Dr. Beck is a past-president of the American Association of Colleges of Pharmacy. During Dr. Beck’s career, her research and scholarship focused on curricular and teaching innovations. Her practice and teaching focused on clinical pharmacokinetics.
Paul L Doering M.S.
Doering is a Emeritus Distinguished Service Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida, College of Pharmacy. He is also Co-director of the statewide Drug Information and Pharmacy Resource Center.
Doering received his Bachelor of Science in Pharmacy from the University of Florida in 1972 and continued his training at the same institution, earning the Master of Science in Clinical Pharmacy in 1975.
Upon graduation, Doering accepted a position in the University’s Department of Medicine as a research assistant where he designed, implemented and evaluated a program of adverse drug reaction monitoring in the obstetric patient.
Current teaching responsibilities include: coordinating a Non-prescription Products course for undergraduate pharmacy students, a senior-level course in Pharmacotherapy, and an elective course in Drug Abuse. He also guest lectures in a variety of team taught courses in the College of Pharmacy and other Health Center colleges.
Doering has strong ties with the practice of pharmacy, having been a practicing pharmacist both in the hospital and community setting. A member of many local, state, and national pharmaceutical societies, he is a past-president of his local pharmacy association.
Doering has been recognized four times as Teacher of the Year. In March, 1990, he was awarded Fellowship status in the APhA’s Academy of Pharmacy Practice and Management. In 1993, he received one of two Teaching Incentive Awards given to UF College of Pharmacy faculty. In 1995, Doering was promoted to Distinguished Service Professor, the university’s highest honor awarded to a faculty member, he was the first professor in the College of Pharmacy to be recognized in this way.
Leslie Hendeles Pharm.D.
Dr. Hendeles is a Professor Emeritus in the College of Pharmacy and also in the Department of Pediatrics at the University of Florida. Among his current research interests are the improvement of adherence to asthma medications and delivery of inhaled drugs to young children. He is a consultant to FDA’s Pulmonary Division, and previously served on the Coordinating Committee of NIH’s Asthma Education Program, as well as CDC’s Expert Panel on Asthma Guidelines for Emergency Medical Services. Dr. Hendeles provides advice on drug therapy and teaches in the Pediatric Pulmonary Clinic at the University of Florida.
Larry Lopez Pharm.D., FCCP, BCPS
Dr. Larry Lopez joined the faculty of the University of Florida College of Pharmacy in September, 1979, after completing requirements for his post-baccalaureate Doctor of Pharmacy degree. Before accepting the faculty appointment he had worked as a community pharmacist and a hospital pharmacist for nearly 10 years. He received his high school diploma in 1964 from Jesuit High School in Tampa, Florida and his Bachelor of Science in Pharmacy from the University of Florida College of Pharmacy in 1969. Dr. Lopez retired from the faculty on November 30, 2011, after 32 years of service.
While a member of the faculty Dr. Lopez was responsible for teaching a number of topics related to the pharmacotherapy of both general internal medicine and cardiovascular disorders for the Colleges of Pharmacy and Medicine. He also maintained clinical practices in Internal Medicine and Anticoagulation at Shands at the University of Florida for the last 10 years of his appointment. Dr. Lopez served as Chairman of the Department of Pharmacy Practice from January, 1997 until July, 2002, Associate Chair of the same department from July, 2002, until July, 2011, when he once again assumed the position of Department Chairman until his retirement later that year.
Dr. Lopez’s research revolved primarily around clinical evaluations of new therapeutic modalities for management of hypertension, myocardial ischemia and/or congestive heart failure. He received over 30 grants and contracts for support of his work in these areas and published approximately 130 abstracts, articles, monographs, and chapters on these and other topics as well. Dr. Lopez was recognized for his research accomplishments by being named as a Fellow of the American College of Clinical Pharmacy and the American Society of Hypertension. He was Board Certified as a Pharmacotherapy Specialist in October, 2004.
AFFILIATIONS American College of Clinical Pharmacy North Central Florida Society of Health-System Pharmacists American Heart Association Florida Society of Health-System Pharmacists Board of Pharmaceutical Specialties
Michael McKenzie Ph.D.
After receiving his master’s degree in 1972 he continued his work as a researcher on the FDA study on the epidemiology of adverse drug reactions in hospitalized pediatric patients until he accepted a position as assistant professor of pharmacy in the College of Pharmacy in Sept. 1972. He assumed clinical pharmacy responsibilities in the pediatric department of Shands Hospital, coordinated the clinical pharmacy clerkship program, lectured on pediatric pharmacy in the therapeutics course, and coordinated an introductory pharmacology course for nursing students. He taught an elective course in pediatric pharmacy and supervised pharmacy students in a pediatric pharmacy clerkship for many years prior to assuming administrative positions in the College of Pharmacy. For 24 years he coordinated and taught a UF Honors Seminar: In Search of Magic Bullets for students in the Honors Program. He was recently recognized by the UF Honors Program as the Honors Professor of the Year for 2015-2016. He helped organize, implement and teach in a new course, Medications and Health, for UF undergraduates in the spring semester 2016.
In 1977 he was promoted to associate professor and decided to take a two year leave of absence to complete requirements for the Doctor of Philosophy degree in clinical pharmacy at Purdue University. After receiving the Ph.D. degree he returned to the College of Pharmacy and assumed clinical pharmacy responsibilities in the pediatric ambulatory clinic and coordinated the therapeutics course. He accepted the position as coordinator of the post-baccalaureate Doctor of Pharmacy program in 1981.
In 1984 he was appointed as assistant dean for student affairs responsible for recruitment, prepharmacy counseling, financial aid, awards, academic performance, registration, examination scheduling, classroom scheduling, and faculty advisement. In 1989 he was promoted to professor of pharmacy in the department of pharmacy practice and as associate dean for student affairs.
Promoted to associate dean for academic and student affairs in 1995, he was given the responsibility over curriculum development and faculty development in addition to student affairs responsibilities. He worked with the college’s curriculum task force and the curriculum committee to assist in the planning, organization, implementation, and evaluation of a new Doctor of Pharmacy curriculum.
In 1999 he was promoted to associate dean for professional affairs with administrative responsibilities in student affairs, academic affairs, and the clinical experiential program. He also was given responsibilities as the College’s Equal Employment Opportunity Officer. In 2005 he was promoted to senior associate dean for professional affairs.
As an administrator in the College of Pharmacy he and the staff in the Office for Student Affairs along with other offices in the College implemented and refined programs and events that have enhanced the services to students and faculty in the College. These include the peer advisor program, faculty advisor program, early academic warning program, orientations, awards ceremonies, open houses, career days, white coating ceremony, commencement ceremonies, computer database for applications and admissions, and recruitment activities. He has chaired the admissions committee, academic and professional standards committee, and financial aid and awards committee during his tenure in the Office for Student Affairs.
He was instrumental in the creation of joint degree programs for pharmacy students to obtain the Doctor of Pharmacy and Master of Physician Assistant degrees, Doctor of Pharmacy and Master of Public Health degrees, Doctor of Pharmacy and Master of Business Administration degrees, and Doctor of Pharmacy and Doctor of Philosophy degrees. He coordinated and advised foreign pharmacists for many years in a special program to allow them to obtain the PharmD degree. He served on the task force to implement the Working Professional Pharm.D. Program for post-baccalaureate pharmacists.
He was one of the first pharmacists in the country to develop a pediatric clinical clerkship site, a pediatric pharmacy course, publish data about the incidence and severity of adverse drug reactions in hospitalized pediatric patients, the prevalence of child abuse and neglect to draw pharmacists’ attention to this problem, and develop innovative, self-instructional, competency-based, multi-media modules on medication interviewing, patient counseling, and medication therapy monitoring. He was selected twice to be a co-recipient of the AACP Lyman Award for the best article in the American Journal of Pharmaceutical Education. He has published over 80 articles and chapters in the professional literature and made numerous presentations at continuing education and professional meetings.
During his tenure in the College, he maintained membership in the American Pharmacists Association, American Association of Colleges of Pharmacy, Florida Pharmaceutical Association, and the Florida Society of Health System Pharmacists. He is also a member of Rho Chi Honorary Pharmaceutical Society and Phi Lambda Sigma National Leadership Society. He served as national President of Phi Lambda Sigma from 1990-1991 and served as the faculty advisor for the Iota Chapter of Phi Lambda Sigma for 28 years. He was selected as the national faculty advisor of the year for Phi Lambda Sigma in 2012. He has served as a member of the Florida Pharmacy Association House of Delegates for many years. In AACP he has served as chairman of the Student Personnel Special Interest Group, chairman of the PCAT Advisory Group, and as a member of the Nominations Committee, Lyman Award Committee, PharmCAS Advisory Panel, and the Constitution and By-Laws Committee. He served on the APhA/ASP-AACP Council of Deans Task Force on Professionalism and the AACP Advisory Group on background checks for pharmacy students.